SPENCER DAYMAN MENINGITIS UK
 United Kingdom  |  Health/Medical

Our sole focus is to fund lifesaving research to find a vaccine to eradicate all forms of meningitis. We feel that focusing on prevention, as opposed to treatment and cure, is the only way to successfully eradicate the disease and prevent its devastating consequences.

More information

 

Meningitis UK was established in 1999 to fund a £500,000 state-of-the-art dedicated meningitis research laboratory in the University of Bristol's School of Medical Sciences. The charity's Chief Executive, Steve Dayman, tragically lost his 14-month old son, Spencer to meningitis and meningococcal septicaemia in 1982. The Spencer Dayman Meningitis Laboratories - named in memory of Spencer - were officially opened in April 2002, and now house a two and a half million pound investment into meningitis research. Since the successful completion of this project, the charity has adopted the working name of Meningitis UK and is now solely focused on the development of vaccines to protect against all forms of meningitis.

Our offer

Research Programme

Awareness Programme

Manage Listing